Actinium Pharmaceuticals Inc (ATNM)
7.38
+0.51
(+7.42%)
USD |
NYAM |
Apr 29, 16:00
7.42
+0.04
(+0.54%)
After-Hours: 20:00
Actinium Pharmaceuticals Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
September 30, 2022 | 1.053M |
June 30, 2022 | 1.241M |
Date | Value |
---|---|
March 31, 2022 | 1.462M |
December 31, 2021 | 1.144M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.053M
Minimum
Sep 2022
1.462M
Maximum
Mar 2022
1.225M
Average
1.192M
Median
Revenue (TTM) Benchmarks
Perspective Therapeutics Inc | 0.00 |
Eli Lilly and Co | 34.12B |
Cellectar Biosciences Inc | -- |
Outlook Therapeutics Inc | -- |
Bristol-Myers Squibb Co | 45.53B |